- Home
- ENGN vs POET Comparison
ENGN vs POET Comparison
Compare ENGN & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENGN
- POET
- Stock Information
- Founded
- ENGN 1999
- POET 1972
- Country
- ENGN Canada
- POET Canada
- Employees
- ENGN N/A
- POET N/A
- Industry
- ENGN
- POET Semiconductors
- Sector
- ENGN
- POET Technology
- Exchange
- ENGN Nasdaq
- POET Nasdaq
- Market Cap
- ENGN 317.6M
- POET 278.3M
- IPO Year
- ENGN N/A
- POET N/A
- Fundamental
- Price
- ENGN $6.31
- POET $6.60
- Analyst Decision
- ENGN Strong Buy
- POET Strong Buy
- Analyst Count
- ENGN 9
- POET 2
- Target Price
- ENGN $29.78
- POET $6.25
- AVG Volume (30 Days)
- ENGN 206.9K
- POET 2.9M
- Earning Date
- ENGN 12-19-2024
- POET 11-14-2024
- Dividend Yield
- ENGN N/A
- POET N/A
- EPS Growth
- ENGN N/A
- POET N/A
- EPS
- ENGN N/A
- POET N/A
- Revenue
- ENGN N/A
- POET $119,946.00
- Revenue This Year
- ENGN N/A
- POET N/A
- Revenue Next Year
- ENGN N/A
- POET $9,744.96
- P/E Ratio
- ENGN N/A
- POET N/A
- Revenue Growth
- ENGN N/A
- POET N/A
- 52 Week Low
- ENGN $4.42
- POET $0.84
- 52 Week High
- ENGN $18.40
- POET $5.87
- Technical
- Relative Strength Index (RSI)
- ENGN 36.65
- POET 72.98
- Support Level
- ENGN $5.60
- POET $4.47
- Resistance Level
- ENGN $6.54
- POET $5.34
- Average True Range (ATR)
- ENGN 0.66
- POET 0.63
- MACD
- ENGN -0.10
- POET 0.12
- Stochastic Oscillator
- ENGN 23.28
- POET 71.35
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
About POET POET Technologies Inc.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The group's operations are located in Allentown, PA, Shenzhen, China, and Singapore.